US 7371372
Compositions comprising IMPDH inhibitors and uses thereof for treating HCV infection
granted A61KA61K38/212A61P
Quick answer
US patent 7371372 (Compositions comprising IMPDH inhibitors and uses thereof for treating HCV infection) held by Vertex Pharmaceuticals Incorporated expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K38/212, A61P, A61P31/14